LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
  • AstraZeneca PLC (LSE: AZN) Latest News

    Female Doctor In White Coat Having Meeting With Woman Patient In Office
    Investing Articles

    As the AstraZeneca share price dips on results day, I ask if the stock is too high

    Earnings are up in 2023, but the AstraZeneca share price just fell. Is the love affair with the Covid vaccine…

    Read more »

    Young Caucasian girl showing and pointing up with fingers number three against yellow background
    Investing Articles

    3 top FTSE 100 stocks that easily pass the ‘snap test’

    Our writer takes a look at a trio of FTSE 100 stocks that would be sorely missed if they vanished…

    Read more »

    One English pound placed on a graph to represent an economic down turn
    Investing Articles

    £7,000 to invest? I’d consider these stocks in the FTSE 100 right now

    Like a resurgent Rolls-Royce, multiple FTSE 100 businesses can sometimes deliver decent returns for investors over a reasonable timescale.

    Read more »

    Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
    Investing Articles

    They outperformed the S&P 500 over 5 years! Are these the best UK shares to buy now?

    Sure, the S&P 500 may deliver impressive returns, but I’m looking at three shares to buy here in the UK…

    Read more »

    positive mental health woman
    Investing Articles

    How I’d invest £20,000 in a Stocks and Shares ISA to target lifelong passive income

    What should investors look for when investing in a Stocks and Shares ISA? Stephen Wright thinks the key for passive…

    Read more »

    Investor looking at stock graph on a tablet with their finger hovering over the Buy button
    Investing Articles

    Down more than 10% in 2023, Fools are backing these 5 UK stocks to reverse that – and then some! – in 2024

    Five Fools see buying opportunities among these beaten-down shares in the UK stock markets!

    Read more »

    The Mall in Westminster, leading to Buckingham Palace
    Investing Articles

    If I had to buy just one FTSE 100 stock in 2024, it would be this

    This Fool considered which FTSE 100 (INDEXFTSE:UKX) stock he’d buy next year if given only one choice. Here’s the champ…

    Read more »

    Concept of two young professional men looking at a screen in a technological data centre
    Investing Articles

    Are these 2 FTSE 100 companies recession-resistant?

    Zaven Boyrazian explores two FTSE 100 giants that could outperform the stock market in the event of a near-term recession…

    Read more »

    Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
    Investing Articles

    Here’s a FTSE 100 giant I’m eyeing up for December!

    This Fool explains why this FTSE 100 pharma giant is on her radar. She plans to snap up shares for…

    Read more »

    Playful senior couple in aprons dancing and smiling while preparing healthy dinner at home
    Investing Articles

    Here’s 1 thriving FTSE 100 stock I’d snap up in November

    Stock market volatility has created some exciting opportunities within FTSE 100 stocks. But is this business currently the best bargain?

    Read more »

    Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
    Value Shares

    UK shares near 52-week lows: 2 I like and 1 I’d avoid

    Edward Sheldon has been scanning the FTSE 350 index for shares trading near their 52-week lows and has identified a…

    Read more »

    Engineer Project Manager Talks With Scientist working on Computer
    Investing Articles

    Does the AstraZeneca share price scream value?

    Dr James Fox takes a closer look at the AstraZeneca share price following the company's Q3 results. Is this growth-focused…

    Read more »